{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:38:57Z","timestamp":1782848337427,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T00:00:00Z","timestamp":1590451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T00:00:00Z","timestamp":1590451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s10067-020-05161-w","type":"journal-article","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T07:03:08Z","timestamp":1590476588000},"page":"3769-3776","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Comparison of persistence rates between allopurinol and febuxostat as first-line urate-lowering therapy in patients with gout: an 8-year retrospective cohort study"],"prefix":"10.1007","volume":"39","author":[{"given":"Aran","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunkyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geun-Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunyoung","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Wook","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5205-3978","authenticated-orcid":false,"given":"Seung-Geun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,26]]},"reference":[{"issue":"10","key":"5161_CR1","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/acr.21772","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S, Kaldas M, Gogia M, Perez-Ruiz F, Taylor W, Liote F, Choi H, Singh JA, Dalbeth N, Kaplan S, Niyyar V, Jones D, Yarows SA, Roessler B, Kerr G, King C, Levy G, Furst DE, Edwards NL, Mandell B, Schumacher HR, Robbins M, Wenger N, Terkeltaub R (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res 64(10):1431\u20131446. https:\/\/doi.org\/10.1002\/acr.21772","journal-title":"Arthritis Care Res"},{"issue":"1","key":"5161_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castaneda-Sanabria J, Coyfish M, Guillo S, Jansen TL, Janssens H, Liote F, Mallen C, Nuki G, Perez-Ruiz F, Pimentao J, Punzi L, Pywell T, So A, Tausche AK, Uhlig T, Zavada J, Zhang W, Tubach F, Bardin T (2017) 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 76(1):29\u201342. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209707","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"5161_CR3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.semarthrit.2017.09.007","volume":"47","author":"L Scheepers","year":"2018","unstructured":"Scheepers L, van Onna M, Stehouwer CDA, Singh JA, Arts ICW, Boonen A (2018) Medication adherence among patients with gout: a systematic review and meta-analysis. Semin Arthritis Rheum 47(5):689\u2013702. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.09.007","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"5161_CR4","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/acr.22336","volume":"66","author":"MA De Vera","year":"2014","unstructured":"De Vera MA, Marcotte G, Rai S, Galo JS, Bhole V (2014) Medication adherence in gout: a systematic review. Arthritis Care Res 66(10):1551\u20131559. https:\/\/doi.org\/10.1002\/acr.22336","journal-title":"Arthritis Care Res"},{"issue":"4","key":"5161_CR5","doi-asserted-by":"publisher","first-page":"e017542","DOI":"10.1136\/bmjopen-2017-017542","volume":"8","author":"R Yin","year":"2018","unstructured":"Yin R, Li L, Zhang G, Cui Y, Zhang L, Zhang Q, Fu T, Cao H, Gu Z (2018) Rate of adherence to urate-lowering therapy among patients with gout: a systematic review and meta-analysis. BMJ Open 8(4):e017542. https:\/\/doi.org\/10.1136\/bmjopen-2017-017542","journal-title":"BMJ Open"},{"issue":"6","key":"5161_CR6","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3109\/14397595.2016.1170914","volume":"26","author":"S Lee","year":"2016","unstructured":"Lee S, So MW (2016) Adherence with urate-lowering therapies among male patients with gout in a routine clinical setting. Mod Rheumatol 26(6):950\u2013955. https:\/\/doi.org\/10.3109\/14397595.2016.1170914","journal-title":"Mod Rheumatol"},{"key":"5161_CR7","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2147\/TCRM.S162956","volume":"14","author":"F Perez-Ruiz","year":"2018","unstructured":"Perez-Ruiz F, Desideri G (2018) Improving adherence to gout therapy: an expert review. Ther Clin Risk Manag 14:793\u2013802. https:\/\/doi.org\/10.2147\/TCRM.S162956","journal-title":"Ther Clin Risk Manag"},{"key":"5161_CR8","doi-asserted-by":"publisher","unstructured":"Nasser-Ghodsi N, Harrold LR (2015) Overcoming adherence issues and other barriers to optimal care in gout. Curr Opin Rheumatol 27(2):134\u2013138. https:\/\/doi.org\/10.1097\/BOR.0000000000000141","DOI":"10.1097\/BOR.0000000000000141"},{"issue":"2","key":"5161_CR9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/BOR.0000000000000573","volume":"31","author":"T Bardin","year":"2019","unstructured":"Bardin T, Richette P (2019) The role of febuxostat in gout. Curr Opin Rheumatol 31(2):152\u2013158. https:\/\/doi.org\/10.1097\/BOR.0000000000000573","journal-title":"Curr Opin Rheumatol"},{"issue":"13","key":"5161_CR10","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1056\/NEJMoa1710895","volume":"378","author":"WB White","year":"2018","unstructured":"White WB, Saag KG, Becker MA, Borer JS, Gorelick PB, Whelton A, Hunt B, Castillo M, Gunawardhana L, Investigators C (2018) Cardiovascular safety of febuxostat or allopurinol in patients with gout. N Engl J Med 378(13):1200\u20131210. https:\/\/doi.org\/10.1056\/NEJMoa1710895","journal-title":"N Engl J Med"},{"issue":"3","key":"5161_CR11","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/art.1780200320","volume":"20","author":"SL Wallace","year":"1977","unstructured":"Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20(3):895\u2013900. https:\/\/doi.org\/10.1002\/art.1780200320","journal-title":"Arthritis Rheum"},{"issue":"10","key":"5161_CR12","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1002\/art.39254","volume":"67","author":"T Neogi","year":"2015","unstructured":"Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJ, Liote F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche AK, Vazquez-Mellado J, Yarows SA, Taylor WJ (2015) 2015 gout classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheumatol 67(10):2557\u20132568. https:\/\/doi.org\/10.1002\/art.39254","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"5161_CR13","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","volume":"74","author":"T Neogi","year":"2015","unstructured":"Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJ, Liote F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche AK, Vaquez-Mellado J, Yarows SA, Taylor WJ (2015) 2015 gout classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 74(10):1789\u20131798. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208237","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5161_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.amjmed.2009.05.026","volume":"123","author":"LR Harrold","year":"2010","unstructured":"Harrold LR, Andrade SE, Briesacher B, Raebel MA, Fouayzi H, Yood RA, Ockene IS (2010) The dynamics of chronic gout treatment: medication gaps and return to therapy. Am J Med 123(1):54\u201359. https:\/\/doi.org\/10.1016\/j.amjmed.2009.05.026","journal-title":"Am J Med"},{"issue":"8","key":"5161_CR15","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1007\/s10067-018-4127-x","volume":"37","author":"CA Janssen","year":"2018","unstructured":"Janssen CA, Oude Voshaar MAH, Vonkeman HE, Krol M, van de Laar M (2018) A retrospective analysis of medication prescription records for determining the levels of compliance and persistence to urate-lowering therapy for the treatment of gout and hyperuricemia in the Netherlands. Clin Rheumatol 37(8):2291\u20132296. https:\/\/doi.org\/10.1007\/s10067-018-4127-x","journal-title":"Clin Rheumatol"},{"issue":"10","key":"5161_CR16","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/acr.21773","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Bae S, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S, Kaldas M, Gogia M, Perez-Ruiz F, Taylor W, Liote F, Choi H, Singh JA, Dalbeth N, Kaplan S, Niyyar V, Jones D, Yarows SA, Roessler B, Kerr G, King C, Levy G, Furst DE, Edwards NL, Mandell B, Schumacher HR, Robbins M, Wenger N, Terkeltaub R (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res 64(10):1447\u20131461. https:\/\/doi.org\/10.1002\/acr.21773","journal-title":"Arthritis Care Res"},{"issue":"6","key":"5161_CR17","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1093\/rheumatology\/kes431","volume":"52","author":"G Zandman-Goddard","year":"2013","unstructured":"Zandman-Goddard G, Amital H, Shamrayevsky N, Raz R, Shalev V, Chodick G (2013) Rates of adherence and persistence with allopurinol therapy among gout patients in Israel. Rheumatology (Oxford) 52(6):1126\u20131131. https:\/\/doi.org\/10.1093\/rheumatology\/kes431","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"5161_CR18","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1136\/ard.2008.092619","volume":"68","author":"JA Singh","year":"2009","unstructured":"Singh JA, Hodges JS, Asch SM (2009) Opportunities for improving medication use and monitoring in gout. Ann Rheum Dis 68(8):1265\u20131270. https:\/\/doi.org\/10.1136\/ard.2008.092619","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"5161_CR19","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1592\/phco.28.4.437","volume":"28","author":"BA Briesacher","year":"2008","unstructured":"Briesacher BA, Andrade SE, Fouayzi H, Chan KA (2008) Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy 28(4):437\u2013443. https:\/\/doi.org\/10.1592\/phco.28.4.437","journal-title":"Pharmacotherapy"},{"issue":"3","key":"5161_CR20","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.clinthera.2012.01.020","volume":"34","author":"H Park","year":"2012","unstructured":"Park H, Rascati KL, Prasla K, McBayne T (2012) Evaluation of health care costs and utilization patterns for patients with gout. Clin Ther 34(3):640\u2013652. https:\/\/doi.org\/10.1016\/j.clinthera.2012.01.020","journal-title":"Clin Ther"},{"issue":"3","key":"5161_CR21","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s10067-014-2823-8","volume":"35","author":"B McGowan","year":"2016","unstructured":"McGowan B, Bennett K, Silke C, Whelan B (2016) Adherence and persistence to urate-lowering therapies in the Irish setting. Clin Rheumatol 35(3):715\u2013721. https:\/\/doi.org\/10.1007\/s10067-014-2823-8","journal-title":"Clin Rheumatol"},{"issue":"4","key":"5161_CR22","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1080\/14397595.2018.1483293","volume":"29","author":"S Lee","year":"2019","unstructured":"Lee S, So MW, Ahn E (2019) Long-term adherence and persistence with febuxostat among male patients with gout in a routine clinical setting. Mod Rheumatol 29(4):662\u2013668. https:\/\/doi.org\/10.1080\/14397595.2018.1483293","journal-title":"Mod Rheumatol"},{"issue":"1","key":"5161_CR23","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12891-017-1514-4","volume":"18","author":"JH Park","year":"2017","unstructured":"Park JH, Park EK, Koo DW, Lee S, Lee SH, Kim GT, Lee SG (2017) Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis. BMC Musculoskelet Disord 18(1):152. https:\/\/doi.org\/10.1186\/s12891-017-1514-4","journal-title":"BMC Musculoskelet Disord"},{"key":"5161_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13047-017-0207-4","volume":"10","author":"S Stewart","year":"2017","unstructured":"Stewart S, Dalbeth N, Otter S, Gow P, Kumar S, Rome K (2017) Clinically-evident tophi are associated with reduced muscle force in the foot and ankle in people with gout: a cross-sectional study. J Foot Ankle Res 10:25. https:\/\/doi.org\/10.1186\/s13047-017-0207-4","journal-title":"J Foot Ankle Res"},{"issue":"5","key":"5161_CR25","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s10067-019-04520-6","volume":"38","author":"IJM Disveld","year":"2019","unstructured":"Disveld IJM, Zoakman S, Jansen T, Rongen GA, Kienhorst LBE, Janssens H, Fransen J, Janssen M (2019) Crystal-proven gout patients have an increased mortality due to cardiovascular diseases, cancer, and infectious diseases especially when having tophi and\/or high serum uric acid levels: a prospective cohort study. Clin Rheumatol 38(5):1385\u20131391. https:\/\/doi.org\/10.1007\/s10067-019-04520-6","journal-title":"Clin Rheumatol"},{"issue":"9","key":"5161_CR26","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604\u2013612. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann Intern Med"},{"issue":"1","key":"5161_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","volume":"11","author":"JA Cramer","year":"2008","unstructured":"Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, Wong PK (2008) Medication compliance and persistence: terminology and definitions. Value Health 11(1):44\u201347. https:\/\/doi.org\/10.1111\/j.1524-4733.2007.00213.x","journal-title":"Value Health"},{"issue":"7","key":"5161_CR28","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1185\/03007990903017966","volume":"25","author":"R Halpern","year":"2009","unstructured":"Halpern R, Mody RR, Fuldeore MJ, Patel PA, Mikuls TR (2009) Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis. Curr Med Res Opin 25(7):1711\u20131719. https:\/\/doi.org\/10.1185\/03007990903017966","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"5161_CR29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/03007995.2019.1688271","volume":"36","author":"JA Park","year":"2020","unstructured":"Park JA, Lee MY, Nam JH, Shin JY, Wood R, Holbrook T, Kwon SH (2020) Real-world treatment persistence of non-tumor necrosis factor inhibitors versus tumor necrosis factor inhibitors among patients with rheumatoid arthritis in South Korea. Curr Med Res Opin 36(2):343\u2013351. https:\/\/doi.org\/10.1080\/03007995.2019.1688271","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"5161_CR30","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1592\/phco.30.6.594","volume":"30","author":"BL Love","year":"2010","unstructured":"Love BL, Barrons R, Veverka A, Snider KM (2010) Urate-lowering therapy for gout: focus on febuxostat. Pharmacotherapy 30(6):594\u2013608. https:\/\/doi.org\/10.1592\/phco.30.6.594","journal-title":"Pharmacotherapy"},{"issue":"4","key":"5161_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrrheum.2015.132","volume":"12","author":"LK Stamp","year":"2016","unstructured":"Stamp LK, Day RO, Yun J (2016) Allopurinol hypersensitivity: investigating the cause and minimizing the risk. Nat Rev Rheumatol 12(4):235\u2013242. https:\/\/doi.org\/10.1038\/nrrheum.2015.132","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"5161_CR32","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1093\/ckj\/sfw076","volume":"9","author":"MN Demian","year":"2016","unstructured":"Demian MN, Shapiro RJ, Thornton WL (2016) An observational study of health literacy and medication adherence in adult kidney transplant recipients. Clin Kidney J 9(6):858\u2013865. https:\/\/doi.org\/10.1093\/ckj\/sfw076","journal-title":"Clin Kidney J"},{"issue":"1","key":"5161_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.colegn.2015.08.003","volume":"24","author":"YM Lee","year":"2017","unstructured":"Lee YM, Yu HY, You MA, Son YJ (2017) Impact of health literacy on medication adherence in older people with chronic diseases. Collegian 24(1):11\u201318. https:\/\/doi.org\/10.1016\/j.colegn.2015.08.003","journal-title":"Collegian"},{"issue":"2","key":"5161_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11606-011-1886-3","volume":"27","author":"LA Lindquist","year":"2012","unstructured":"Lindquist LA, Go L, Fleisher J, Jain N, Friesema E, Baker DW (2012) Relationship of health literacy to intentional and unintentional non-adherence of hospital discharge medications. J Gen Intern Med 27(2):173\u2013178. https:\/\/doi.org\/10.1007\/s11606-011-1886-3","journal-title":"J Gen Intern Med"},{"issue":"9","key":"5161_CR35","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s10067-014-2838-1","volume":"34","author":"M van Onna","year":"2015","unstructured":"van Onna M, Hinsenveld E, de Vries H, Boonen A (2015) Health literacy in patients dealing with gout: a qualitative study. Clin Rheuamtol 34(9):1599\u20131603. https:\/\/doi.org\/10.1007\/s10067-014-2838-1","journal-title":"Clin Rheuamtol"},{"issue":"1","key":"5161_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003627","volume":"4","author":"RD Goldfien","year":"2014","unstructured":"Goldfien RD, Ng MS, Yip G, Hwe A, Jacobson A, Pressman A, Avins AL (2014) Effectiveness of a pharmacist-based gout care management programme in a large integrated health plan: results from a pilot study. BMJ Open 4(1):e003627. https:\/\/doi.org\/10.1136\/bmjopen-2013-003627","journal-title":"BMJ Open"},{"issue":"6","key":"5161_CR37","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1136\/annrheumdis-2012-201676","volume":"72","author":"F Rees","year":"2013","unstructured":"Rees F, Jenkins W, Doherty M (2013) Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study. Ann Rheum Dis 72(6):826\u2013830. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201676","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"5161_CR38","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1136\/ard.2007.076182","volume":"67","author":"DH Solomon","year":"2008","unstructured":"Solomon DH, Avorn J, Levin R, Brookhart MA (2008) Uric acid lowering therapy: prescribing patterns in a large cohort of older adults. Ann Rheum Dis 67(5):609\u2013613. https:\/\/doi.org\/10.1136\/ard.2007.076182","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"5161_CR39","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/rheumatology\/keh587","volume":"44","author":"R Neame","year":"2005","unstructured":"Neame R, Hammond A (2005) Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis. Rheumatology (Oxford) 44(6):762\u2013767. https:\/\/doi.org\/10.1093\/rheumatology\/keh587","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"5161_CR40","doi-asserted-by":"publisher","first-page":"925","DOI":"10.4065\/81.7.925","volume":"81","author":"CA Sarawate","year":"2006","unstructured":"Sarawate CA, Brewer KK, Yang W, Patel PA, Schumacher HR, Saag KG, Bakst AW (2006) Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin Proc 81(7):925\u2013934. https:\/\/doi.org\/10.4065\/81.7.925","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"5161_CR41","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1007\/s00296-015-3284-3","volume":"35","author":"N Rashid","year":"2015","unstructured":"Rashid N, Levy GD, Wu YL, Zheng C, Koblick R, Cheetham TC (2015) Patient and clinical characteristics associated with gout flares in an integrated healthcare system. Rheumatol Int 35(11):1799\u20131807. https:\/\/doi.org\/10.1007\/s00296-015-3284-3","journal-title":"Rheumatol Int"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05161-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05161-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05161-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T23:50:16Z","timestamp":1621986616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05161-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,26]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5161"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05161-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,26]]},"assertion":[{"value":"30 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Ethical approval was obtained via the Research and Ethical Review Board of Pusan National University Hospital, which waived informed consent due to retrospective study design (IRB no. 1912\u2013021-086).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}